Yuexiu-finance
Yuexiu Financial Holdings was listed in the main board of Shenzhen Stock Exchange in 2
Guangzhou Yuexiu Financial Holdings Group, founded in 1992, was listed in the main board of Shenzhen Stock Exchange in 2000, is the first local financial holdings listed platform in China, has controls over several financial institutions, and is the second-largest shareholder of CITIC Securities. The business areas include securities, financial leasing, industrial fund, guarantee, microcredit and merchandise. Its major shareholders are Guangzhou Yuexiu Holding, Guangzhou State-owned Asset Development Holding, and Guangzhou Hengyun Enterprises Holdings. Its direct and indirect competitors include CNPC Capital, Avic Capital and Minmetals Capital.
The index recovered, and the gem index and Shanghai index once turned red
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Donghua Technology: pre winning the EPC project of ammonium dihydrogen phosphate project for battery
Bufeng international calls out the list of Hong Kong stocks under Shenzhen Hong Kong stock connect
Services Provider Haixin Zhihui Raises CNY Hundreds of Mns in Series B Funding
Founded in January 2018, Haixin Zhihui is an artificial intelligence company focusing on the oncology field, it specializes in intelligent tumor diagnosis and treatment and has developed the first oncology intelligent diagnosis and treatment system in China.
Yesterday 04:04 PM
Public REITs will be expanded, and three new products have been accepted
The 2021 Financial Street forum annual meeting will be held in Beijing in late October
Junshi Announces Its Anti-Covid Phase III Drug Reaches Primary Endpoint
Founded in August 2021, Juntuo Biotech is dedicated to the R&D processes in biomedicine and vaccines. The company's innovative R&D pipelines cover viral vaccines, bacterial vaccines, genetically engineered vaccines, conjugate vaccines, and multivalent vaccines.
May 24, 2022 03:45 PM
Boteng: net profit in the first half of the year increased by 60% - 70% year on year
Yuexiu Fengxing agriculture and animal husbandry signed a contract with Jiangsu Donghe group for the whole industry chain cooperation project of one million pigs